Teligent Announces Conversion Rate Adjustment for its 7.0% Cash / 8.0% PIK Series B Senior Unsecured Convertible Notes Due 2023 and its 4.75% Convertible Senior Notes Due 2023
June 03, 2020 16:15 ET
|
Teligent, Inc.
BUENA, N.J., June 03, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, announced today conversion...
Teligent Announces One-for-Ten Reverse Stock Split
May 26, 2020 16:30 ET
|
Teligent, Inc.
BUENA, N.J., May 26, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, announced today that as of...
Teligent, Inc. Announces First Quarter 2020 Results
May 22, 2020 07:30 ET
|
Teligent, Inc.
BUENA, N.J., May 22, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the first quarter...
Teligent, Inc. to Hold Conference Call for First Quarter 2020 Results on Friday May 22nd, 2020
May 19, 2020 17:00 ET
|
Teligent, Inc.
BUENA, N.J., May 19, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, announced they will hold a conference call at 8:00AM ET on...
TELIGENT, INC. ANNOUNCES FOURTH QUARTER AND YEAR END 2019 RESULTS & AMENDMENTS TO EXISTING SECURED CREDIT FACILITIES
April 08, 2020 07:30 ET
|
Teligent, Inc.
BUENA, N.J., April 08, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the fourth...
Teligent, Inc. to Hold Conference Call for Fourth Quarter and 2019 Full Year Financial Results on Wednesday April 8, 2020
April 03, 2020 16:05 ET
|
Teligent, Inc.
BUENA, N.J., April 03, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, announced they will hold a conference call at 8:00 a.m. ET...
Teligent, Inc. Announces Transition in Leadership
February 05, 2020 08:21 ET
|
Teligent, Inc.
BUENA, N.J., Feb. 05, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey based specialty generic pharmaceutical company, today announced a transition...
Teligent, Inc. Announces FDA Request for Further Data on Complex Drug
December 23, 2019 17:12 ET
|
Teligent, Inc.
BUENA, N.J., Dec. 23, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its development partner has received a...
Teligent, Inc. to Present at Jefferies Global Healthcare Conference in London on Wednesday November 20, 2019
November 13, 2019 12:30 ET
|
Teligent, Inc.
BUENA, N.J., Nov. 13, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at Jefferies Global Healthcare...
Teligent, Inc. Announces Third Quarter 2019 Results
November 04, 2019 16:15 ET
|
Teligent, Inc.
BUENA, N.J., Nov. 04, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the third quarter...